So far, a high level of HSPA2 in tumor was reported as a negative prognostic factor in esophageal cancer [43], hepatocellular cancer [44], pancreatic cancer [45,46], and NSCLC [22]. This evidence concerns the gene HSPA2 and hepatocellular carcinoma.